Press "Enter" to skip to content

New patent for Merck Sharp drug ISENTRESS

0
Copyright © DrugPatentWatch. Originally published at New patent for Merck Sharp drug ISENTRESS

Annual Drug Patent Expirations for ISENTRESS
Annual Drug Patent Expirations for ISENTRESS

Isentress is a drug marketed by Merck Sharp Dohme and is included in three NDAs. It is available from six suppliers. There are five patents protecting this drug and one Paragraph IV challenge.

ISENTRESS drug price trends.

The generic ingredient in ISENTRESS is raltegravir potassium. Six suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Merck Sharp drug ISENTRESS
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!